Key Metrics
Q4
Mathematics (all)
SJR
- Q4 Mathematics (all)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
Indexed in the following public directories
-
Web of Science -
DOAJ
Topics Covered
- Antitumor response
- Immune modulation
- Clinical trial
- VLA-4
- Metabolic reprogramming
- Antigen
- B-cell lymphoma
- Monoclonal antibody
- Chimeric antigen receptor
- Cancer immunotherapy
- Steady state
Journal Specifications
| Overview | |
| Publisher | Oxford University Press |
| Language | English |
| Article Processing Charges | GBP 2100 |
| Publication Time | 7 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | British Society for Immunology |
| Website URL | Visit website |
| Publication Details | |
| Waiver Policy | Visit website |
| Publication Time | 7 |
| Article Processing Charges | GBP 2100 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Immunotherapy Advances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Delivery of IL-12 by neoantigen-reactive T cells promotes antitumor immunity in murine osteosarcoma mode
- 28 Nov 24
- Immunotherapy Advances
-
Full paper
Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults
- 27 Nov 24
- Immunotherapy Advances
-
Full paper
Hyperactivation of the PI3K Pathway in Inborn Errors of Immunity: current understanding and therapeutic perspectives
- 7 Nov 24
- Immunotherapy Advances
-
Full paper
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer testis antigen PRAME
- 2 Nov 24
- Immunotherapy Advances
-
Full paper
Establishment of humanised xenograft models as in vivo study for lung metastasis of osteosarcoma.
- 23 Mar 24
- Immunotherapy advances
-
Full paper
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study.
- 1 Jan 24
- Immunotherapy Advances
Scite analysis
Powered by scite_
99 articles received 464 citations see all
- 12 Supporting
- 451 Mentioning
- 1 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 6 Corrections
- 2 Errata
- 0 Expression of Concern
FAQs
How many articles did Immunotherapy Advances publish last years ?
In 2023, Immunotherapy Advances published 32 articles.
What is the SJR for Immunotherapy Advances ?
SJR for Immunotherapy Advances is Q4.
Who is the publisher of Immunotherapy Advances ?
Oxford University Press is the publisher of Immunotherapy Advances.